Aspen Pharmacare Holdings (APN.JO) Saham Harga
Aspen Pharmacare Holdings Harga
Selama 19 tahun terakhir pendapatan Aspen Pharmacare Holdings tumbuh 12,0% per tahun, mencapai 34,87 miliar ZAR. Laba per saham tumbuh 6,1% per tahun selama 19 tahun terakhir. Bagi Aspen Pharmacare Holdings, margin bersih sebesar 7,6% turun dibanding 16,8% beberapa tahun lalu. Pada harga saat ini imbal hasil dividen sekitar 1,28%. Rasio pembayaran sekitar 28% dari laba. Dividen tumbuh 6,1% per tahun selama 19 tahun terakhir. Target harga konsensus 12 bulan untuk Aspen Pharmacare Holdings adalah 117,30 ZAR, sekitar di bawah harga saat ini 28,7%. Dari 10 analis, 0 merekomendasikan beli — konsensus keseluruhan Tahan.
Harga saham Aspen Pharmacare Holdings
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Aspen Pharmacare Holdings
Pertanyaan yang sering diajukan tentang saham Aspen Pharmacare Holdings
The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.
Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.
The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.
Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.
Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.
Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.
Analis saat ini menetapkan target harga rata-rata 120,02 ZAR untuk saham Aspen Pharmacare Holdings (median: 117,30 ZAR), yaitu -27,0 % terhadap harga terbaru. Konsensus didasarkan pada 10 peringkat analis.
10 analis saat ini menilai saham Aspen Pharmacare Holdings: 0 merekomendasikan beli, 6 tahan, dan 4 jual.
Dengan kurs saat ini, saham Aspen Pharmacare Holdings diperdagangkan pada 8,84 EUR (164,45 ZAR).
Saham Aspen Pharmacare Holdings (APN.JO) tercatat di 5 bursa, termasuk: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).
Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.
Pendapatan dari Aspen Pharmacare Holdings adalah 34,87 miliar ZAR. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba dari Aspen Pharmacare Holdings adalah 2,65 miliar ZAR. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Aspen Pharmacare Holdings saat ini adalah 27,55. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Aspen Pharmacare Holdings.
Rasio harga-terhadap-penjualan (PSR) Aspen Pharmacare Holdings saat ini adalah 2,09. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Aspen Pharmacare Holdings.
Skor Kualitas AlleAktien untuk Aspen Pharmacare Holdings adalah 1/10.
ISIN dari Aspen Pharmacare Holdings adalah ZAE000066692. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Aspen Pharmacare Holdings adalah A0ET80. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Aspen Pharmacare Holdings adalah APN.JO. Simbol ticker digunakan untuk memperdagangkan saham Aspen Pharmacare Holdings di bursa saham.
Saham Aspen Pharmacare Holdings
Kelompok Peer Aspen Pharmacare Holdings
Aspen Pharmacare Holdings Ticker
Aspen Pharmacare Holdings FIGI
Semua metrik fundamental dan analisis mendalam Aspen Pharmacare Holdings
Analisis saham kami untuk saham Aspen Pharmacare Holdings mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Aspen Pharmacare Holdings. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.